Trial Profile
Prospective randomized study of Recombinant human bone morphogenetic protein (rhBMP)-2 in cleft lip patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Dibotermin alfa (Primary)
- Indications Cleft lip
- Focus Therapeutic Use
- 06 Nov 2015 New trial record